Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10612studies shown

Showing 3,433-3,444 of 10,612

Other study type icon

CompletedNCT02566980

Biological Triggers of Depression in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionObservationalOver 18 Years

Countries: United States
Sponsor: Michigan State University
Condition: Depression

Drug study icon

CompletedNCT02805972

Biology and Experience of Eating in Women With Obesity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 18 Years to 45 Years

Countries: United States
Sponsor: University of California, San Francisco
Condition: Eating disorders

Drug study icon

CompletedNCT02404155

Biomarker and Safety Study of Clozapine in people with Benign Ethnic Neutropenia (BEN)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Behavioral study icon

CompletedNCT03343028

Biomarker Establishment for Superior Treatment of PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 60 Years

Countries: United States
Sponsor: Stanford University
Condition: PTSD

Behavioral study icon

CompletedNCT02431611

Biomarker Feedback to Motivate Cessation in Pregnancy

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 45 Years

Countries: United States
Sponsor: Mayo Clinic
Condition: Addiction

Drug study icon

CompletedNCT01555697

Biomarker Strategies for Medication-Enhanced Cognitive Training in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of California, San Diego
Condition: Schizophrenia

Drug study icon

CompletedNCT00688324

Biomarker Study of Acamprosate in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: University of Maryland, Baltimore
Condition: Schizophrenia

Other study type icon

CompletedNCT03014518

Biomarkers as Predictors of Suicidal Risk in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityObservationalFrom 12 Years to 18 Years

Countries: United States
Sponsor: The Cleveland Clinic
Condition: Suicidality

Other study type icon

CompletedNCT02033382

Biomarkers in First Episode Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaObservationalFrom 16 Years to 40 Years

Countries: United States
Sponsor: NYU Langone Health
Condition: Schizophrenia

Drug study icon

CompletedNCT00817336

Biomarkers in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States
Sponsor: Nathan Kline Institute for Psychiatric Research
Condition: Schizophrenia

Drug study icon

CompletedNCT05650775

Biomarkers of ADHD Treatment Response

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 7 Years to 11 Years

Countries: United States
Sponsor: Boston Children's Hospital
Condition: ADHD

Drug study icon

CompletedNCT03323437

Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 35 Years

Countries: United States
Sponsor: Weill Medical College of Cornell University
Condition: Schizophrenia

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.